Antibacterial Peptide Nucleic Acids-Facts and Perspectives.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
28 Jan 2020
Historique:
received: 28 12 2019
revised: 20 01 2020
accepted: 22 01 2020
entrez: 5 2 2020
pubmed: 6 2 2020
medline: 13 11 2020
Statut: epublish

Résumé

Antibiotic resistance is an escalating, worldwide problem. Due to excessive use of antibiotics, multidrug-resistant bacteria have become a serious threat and a major global healthcare problem of the 21st century. This fact creates an urgent need for new and effective antimicrobials. The common strategies for antibiotic discovery are based on either modifying existing antibiotics or screening compound libraries, but these strategies have not been successful in recent decades. An alternative approach could be to use gene-specific oligonucleotides, such as peptide nucleic acid (PNA) oligomers, that can specifically target any single pathogen. This approach broadens the range of potential targets to any gene with a known sequence in any bacterium, and could significantly reduce the time required to discover new antimicrobials or their redesign, if resistance arises. We review the potential of PNA as an antibacterial molecule. First, we describe the physicochemical properties of PNA and modifications of the PNA backbone and nucleobases. Second, we review the carriers used to transport PNA to bacterial cells. Furthermore, we discuss the PNA targets in antibacterial studies focusing on antisense PNA targeting bacterial mRNA and rRNA.

Identifiants

pubmed: 32012929
pii: molecules25030559
doi: 10.3390/molecules25030559
pmc: PMC7038079
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Nucleic Acids 0
Peptide Nucleic Acids 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Science Centre, Poland
ID : UMO-2016/23/B/NZ1/03198 and 2017/25/N/NZ1/01578

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

J Biotechnol. 2017 Oct 10;259:148-159
pubmed: 28764969
J Phys Chem B. 2017 Apr 13;121(14):2968-2979
pubmed: 28301169
J Phys Chem B. 2013 Oct 3;117(39):11584-95
pubmed: 23972113
Org Biomol Chem. 2012 Jan 28;10(4):876-81
pubmed: 22159214
Microb Cell Fact. 2007 Aug 10;6:24
pubmed: 17692125
Science. 1994 Aug 5;265(5173):777-80
pubmed: 7519361
Front Microbiol. 2019 May 24;10:1032
pubmed: 31178830
Artif DNA PNA XNA. 2012 Apr-Jun;3(2):80-7
pubmed: 22772036
Nucleic Acids Res. 1997 Nov 15;25(22):4639-43
pubmed: 9358176
Front Microbiol. 2018 Nov 26;9:2870
pubmed: 30534121
Nucleic Acids Res. 1998 Jan 15;26(2):566-75
pubmed: 9421517
J Mol Biol. 2012 Jun 8;419(3-4):125-38
pubmed: 22459262
Science. 1991 Dec 6;254(5037):1497-500
pubmed: 1962210
Biochem Pharmacol. 1994 Sep 15;48(6):1310-3
pubmed: 7945427
PLoS One. 2015 Oct 15;10(10):e0140468
pubmed: 26469337
Sci Rep. 2017 Aug 9;7(1):7644
pubmed: 28794451
Int J Mol Sci. 2019 Mar 13;20(6):
pubmed: 30871132
Biochemistry. 2019 Aug 13;58(32):3444-3453
pubmed: 31318532
Nucleic Acid Ther. 2017 Jun;27(3):176-181
pubmed: 28080251
Angew Chem Int Ed Engl. 2012 Dec 7;51(50):12593-6
pubmed: 23125029
Nucleic Acids Res. 2006;34(16):4354-63
pubmed: 16936319
Microbiology. 2009 Aug;155(Pt 8):2603-2611
pubmed: 19477903
J Am Chem Soc. 2004 Nov 24;126(46):15067-73
pubmed: 15548003
J Am Chem Soc. 2008 Oct 8;130(40):13264-73
pubmed: 18781753
Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):5953-8
pubmed: 11972051
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
J Org Chem. 2011 Jul 15;76(14):5614-27
pubmed: 21619025
Chembiochem. 2019 Dec 13;20(24):3041-3051
pubmed: 31206960
J Am Chem Soc. 2005 Feb 9;127(5):1424-30
pubmed: 15686374
Curr Opin Microbiol. 2016 Oct;33:47-55
pubmed: 27375107
Int J Antimicrob Agents. 2013 Apr;41(4):358-62
pubmed: 23305655
Nucleic Acid Ther. 2012 Oct;22(5):323-34
pubmed: 23030590
J Vis Exp. 2017 Sep 21;(127):
pubmed: 28994801
Bioconjug Chem. 2006 May-Jun;17(3):750-8
pubmed: 16704214
J Am Chem Soc. 2010 Aug 11;132(31):10717-27
pubmed: 20681704
Mol Biosyst. 2010 Sep;6(9):1619-29
pubmed: 20386807
Biochim Biophys Acta. 2010 Oct;1798(10):1864-75
pubmed: 20599694
Mol Ther Nucleic Acids. 2012 Jun 12;1:e27
pubmed: 23344079
Microb Pathog. 2020 Feb;139:103907
pubmed: 31811888
Chemistry. 2019 Mar 21;25(17):4367-4372
pubmed: 30746843
Curr Opin Chem Biol. 2019 Oct;52:112-124
pubmed: 31541865
Methods Mol Biol. 2002;208:59-88
pubmed: 12229299
Sci Rep. 2017 Feb 17;7:42799
pubmed: 28211525
J Antimicrob Chemother. 2017 Jan;72(1):137-144
pubmed: 27986898
PLoS One. 2012;7(5):e35774
pubmed: 22586450
Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):11804-8
pubmed: 10518531
Mol Ther. 2004 Oct;10(4):652-9
pubmed: 15451449
P T. 2015 May;40(5):344-52
pubmed: 25987823
Nucleosides Nucleotides Nucleic Acids. 2011 Feb;30(2):97-112
pubmed: 21360408
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
Nucleic Acids Res. 2005 Nov 30;33(21):6837-49
pubmed: 16321967
Org Lett. 2007 Oct 25;9(22):4503-6
pubmed: 17915883
J Am Chem Soc. 2001 Aug 1;123(30):7414-22
pubmed: 11472173
Mol Ther Nucleic Acids. 2019 Dec 6;18:444-454
pubmed: 31655262
Chem Commun (Camb). 2002 Oct 7;(19):2206-7
pubmed: 12397980
Antimicrob Agents Chemother. 2012 Dec;56(12):6407-9
pubmed: 23006748
J Org Chem. 2019 Nov 1;84(21):13252-13261
pubmed: 31547656
Nucleic Acids Res. 1993 May 11;21(9):2103-7
pubmed: 8502550
Mol Ther Nucleic Acids. 2013 Nov 05;2:e132
pubmed: 24193033
J Phys Chem B. 2016 Aug 25;120(33):8369-78
pubmed: 27105576
Acta Crystallogr D Biol Crystallogr. 2012 Aug;68(Pt 8):1067-70
pubmed: 22868773
Chem Commun (Camb). 2016 Jun 28;52(51):7935-8
pubmed: 27157071
Antimicrob Agents Chemother. 2007 Mar;51(3):805-11
pubmed: 17158940
Biomaterials. 2012 Jan;33(2):659-67
pubmed: 22000398
Org Lett. 2009 Nov 5;11(21):4878-81
pubmed: 19788268
J Biomol Struct Dyn. 2004 Feb;21(4):495-502
pubmed: 14692794
Chemistry. 2010 Oct 18;16(39):11867-75
pubmed: 20859960
Nucleic Acids Res. 1999 Dec 15;27(24):4801-6
pubmed: 10572181
Bioorg Med Chem Lett. 2018 Oct 1;28(18):3094-3098
pubmed: 30082123
Bioconjug Chem. 2002 May-Jun;13(3):676-8
pubmed: 12009961
ACS Chem Biol. 2013 Feb 15;8(2):360-7
pubmed: 23138594
Chembiochem. 2005 Jan;6(1):69-77
pubmed: 15584015
PLoS One. 2014 Feb 18;9(2):e89082
pubmed: 24558473
Antimicrob Agents Chemother. 1996 Aug;40(8):1801-5
pubmed: 8843284
J Am Chem Soc. 2005 Mar 30;127(12):4144-5
pubmed: 15783176
J Microbiol. 2019 Jun;57(6):423-430
pubmed: 31054136
J Clin Invest. 1971 May;50(5):1100-7
pubmed: 4994753
Microbiology. 2000 Oct;146 ( Pt 10):2665-2670
pubmed: 11021941
J Org Chem. 2012 Jul 6;77(13):5696-704
pubmed: 22676429
J Infect Dev Ctries. 2017 Feb 28;11(2):212-214
pubmed: 28248687
Chem Commun (Camb). 2016 May 25;52(42):6930-3
pubmed: 27147261
Org Biomol Chem. 2008 Sep 7;6(17):3171-6
pubmed: 18698477
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12021-6
pubmed: 14512516
Nucleic Acids Res. 2016 Feb 29;44(4):1937-43
pubmed: 26717983
Beilstein J Org Chem. 2014 Jul 02;10:1495-503
pubmed: 25161706
Sci Rep. 2016 Feb 10;6:20832
pubmed: 26860980
J Am Chem Soc. 2002 Apr 3;124(13):3254-62
pubmed: 11916408
J Phys Chem B. 2019 Oct 3;123(39):8168-8177
pubmed: 31491077
Org Biomol Chem. 2013 Apr 14;11(14):2310-7
pubmed: 23423157
Nucleic Acids Res. 2007;35(7):e49
pubmed: 17341467
Curr Protoc Nucleic Acid Chem. 2014 Sep 08;58:4.60.1-23
pubmed: 25199637
Curr Top Med Chem. 2007;7(7):667-79
pubmed: 17430208
J Mol Microbiol Biotechnol. 2005;9(2):101-9
pubmed: 16319499
Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2073-6
pubmed: 9482840
J Antimicrob Chemother. 2009 May;63(5):946-8
pubmed: 19279049
J Chem Theory Comput. 2018 Jul 10;14(7):3603-3620
pubmed: 29791152
Org Biomol Chem. 2007 Jan 21;5(2):249-59
pubmed: 17205168
Appl Microbiol Biotechnol. 2010 Mar;86(2):397-402
pubmed: 20135118
Anal Chem. 2014 Dec 16;86(24):11992-8
pubmed: 25415469
Phys Chem Chem Phys. 2014 Feb 7;16(5):1868-74
pubmed: 24327011
Org Lett. 2000 Sep 7;2(18):2825-8
pubmed: 10964375
Org Lett. 2001 May 3;3(9):1269-72
pubmed: 11348211
Nat Struct Biol. 1996 May;3(5):410-3
pubmed: 8612069
P T. 2015 Apr;40(4):277-83
pubmed: 25859123
J Antimicrob Chemother. 2005 Jul;56(1):97-103
pubmed: 15914490
Nanomedicine. 2018 Apr;14(3):745-758
pubmed: 29341934
Adv Genet. 2006;56:1-51
pubmed: 16735154
Biochimie. 2017 Jul;138:32-42
pubmed: 28396015
Analyst. 2019 Feb 25;144(5):1565-1574
pubmed: 30656297
Yale J Biol Med. 2017 Dec 19;90(4):583-598
pubmed: 29259523
PLoS One. 2012;7(1):e29886
pubmed: 22253815
Acta Pharmacol Sin. 2017 Jun;38(6):798-805
pubmed: 28414202
Nucleic Acids Res. 1998 Jun 1;26(11):2735-9
pubmed: 9592162
Mol Biol Rep. 2014 Nov;41(11):7535-41
pubmed: 25091942
Mol Ther. 2017 May 3;25(5):1069-1075
pubmed: 28366767
Nano Lett. 2018 Sep 12;18(9):5652-5659
pubmed: 30088771
ACS Chem Biol. 2013;8(6):1101-9
pubmed: 23631412
PLoS One. 2014 Aug 15;9(8):e104999
pubmed: 25127364
Medchemcomm. 2016;7(1):50-68
pubmed: 27019689
Bioconjug Chem. 2016 Apr 20;27(4):863-7
pubmed: 26938833
Science. 1995 Dec 15;270(5243):1838-41
pubmed: 8525381
Molecules. 2012 Dec 27;18(1):287-310
pubmed: 23271467
Nat Struct Biol. 1997 Feb;4(2):98-101
pubmed: 9033585
Org Lett. 2002 Dec 12;4(25):4395-8
pubmed: 12465896
Antimicrob Agents Chemother. 2005 Aug;49(8):3203-7
pubmed: 16048926
Nucleic Acids Res. 2014 Apr;42(6):4008-18
pubmed: 24423869
J Phys Chem B. 2011 Jan 27;115(3):532-46
pubmed: 21192664
Artif DNA PNA XNA. 2011 Jan;2(1):33-37
pubmed: 21686250
mBio. 2016 Apr 19;7(2):e00345-16
pubmed: 27094328
Org Biomol Chem. 2019 Aug 28;17(34):7874-7877
pubmed: 31424467
Nat Biotechnol. 2001 Apr;19(4):360-4
pubmed: 11283595
Appl Microbiol Biotechnol. 2009 Oct;84(6):1161-8
pubmed: 19578844
Nucleic Acids Res. 1995 Jan 25;23(2):217-22
pubmed: 7862524
Chemistry. 2018 Dec 12;24(70):18772-18778
pubmed: 30286265
Bioorg Med Chem Lett. 2011 Dec 15;21(24):7317-20
pubmed: 22050888

Auteurs

Monika Wojciechowska (M)

Centre of New Technologies, University of Warsaw, Banacha 2c, 02-097 Warsaw, Poland.

Marcin Równicki (M)

Centre of New Technologies, University of Warsaw, Banacha 2c, 02-097 Warsaw, Poland.
College of Inter-Faculty Individual Studies in Mathematics and Natural Sciences, University of Warsaw, Banacha 2c, 02-097 Warsaw, Poland.

Adam Mieczkowski (A)

Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawińskiego 5a, 02-106 Warsaw, Poland.

Joanna Miszkiewicz (J)

Centre of New Technologies, University of Warsaw, Banacha 2c, 02-097 Warsaw, Poland.
College of Inter-Faculty Individual Studies in Mathematics and Natural Sciences, University of Warsaw, Banacha 2c, 02-097 Warsaw, Poland.

Joanna Trylska (J)

Centre of New Technologies, University of Warsaw, Banacha 2c, 02-097 Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH